In last trading session, Quince Therapeutics Inc (NASDAQ:QNCX) saw 92109.0 shares changing hands with its beta currently measuring 0.73. Company’s recent per share price level
Quince Therapeutics Inc (NASDAQ:QNCX) has a beta value of 0.73 and has seen 1.05 million shares traded in the last trading session. The company, currently
Quince Therapeutics Inc (NASDAQ:QNCX)’s traded shares stood at 1.01 million during the last session, with the company’s beta value hitting 0.71. At the close of
Quince Therapeutics Inc (NASDAQ:QNCX)’s traded shares stood at 0.62 million during the last session, with the company’s beta value hitting 0.71. At the last check
During the last session, Quince Therapeutics Inc (NASDAQ:QNCX)’s traded shares were 2.18 million, with the beta value of the company hitting 0.85. At the end
During the last session, Quince Therapeutics Inc (NASDAQ:QNCX)’s traded shares were 12.48 million, with the beta value of the company hitting 0.86. At the end
In today’s recent session, 10.29 million shares of the Quince Therapeutics Inc (NASDAQ:QNCX) have been traded, and its beta is 0.86. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
